DarioHealth Corp. (DRIO) — Financial statements
Income statement, balance sheet, and cash flow for DarioHealth Corp. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 22↓17.3% | 27↑32.9% | 20↓26.4% | 28↑34.8% | 21 | |
| Cost of Revenue | 10↓29.6% | 14↓4.1% | 14↓20.2% | 18↑44.7% | 12 | |
| Gross Profit | 13↓4.5% | 13↑121.7% | 6↓38.0% | 10↑19.7% | 8 | |
| Operating Expenses | ||||||
| R&D Expenses | 14↓43.0% | 24↑19.4% | 20↑3.0% | 20↑14.1% | 17 | |
| General & Administrative Expenses | 15↓25.8% | 20↑13.7% | 18↑9.2% | 16↓27.2% | 23 | |
| Selling & Marketing Expenses | 20↓22.8% | 26↑10.8% | 24↓21.6% | 30↓23.6% | 40 | |
| SG&A Expenses | 36↓24.1% | 47↑12.0% | 42↓10.7% | 47↓24.9% | 62 | |
| Other Expenses | 0.00 | 0.00↓100.0% | 0.13 | 0.00↓100.0% | 5 | |
| Operating Expenses | 49↓30.5% | 71↑14.2% | 62↓6.5% | 66↓21.4% | 85 | |
| Total Costs & Expenses | 59↓30.4% | 85↑11.0% | 76↓9.5% | 84↓12.9% | 97 | |
| Operating Results | ||||||
| Operating Income | -37↑36.5% | -58↓2.8% | -56↑1.1% | -57↑25.7% | -76 | |
| Depreciation & Amortization | 4↓52.1% | 7↑49.0% | 5↑5.7% | 5↑5.8% | 4 | |
| EBITDA | -33↑34.2% | -50↑7.5% | -54↑2.2% | -56↑20.6% | -70 | |
| EBIT | -37↑36.5% | -58↑2.7% | -59↑1.6% | -60↑19.0% | -74 | |
| Interest & Other Income | ||||||
| Net Interest Income | -2↓336.9% | 1↓16.6% | 1↑156.2% | -2↓5342.5% | -0.04 | |
| Interest Income | 0.94↓15.5% | 1↓40.3% | 2↑269.2% | 0.51↑1050.0% | 0.04 | |
| Interest Expense | 3↑3399.0% | 0.10↓85.1% | 0.65↓76.0% | 3↑3094.0% | 0.08 | |
| Non-Operating Income | 0.00 | 0.00↓100.0% | 3↓9.4% | 4↑273.4% | -2 | |
| Other Income / Expenses | -5↓137.7% | 13↑514.1% | -3↑41.0% | -5↓2188.9% | -0.24 | |
| Income Before Tax | -42↑6.7% | -45↑24.9% | -59↑4.5% | -62↑18.9% | -77 | |
| Income Tax Expense | 0.11↑105.7% | -2↓2993.8% | 0.06↑1500.0% | 0.00↓87.5% | 0.03 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -42↑2.4% | -43↑28.1% | -59↑4.4% | -62↑19.0% | -77 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -42↑2.4% | -43↑28.1% | -59↑4.4% | -62↑19.0% | -77 | |
| Bottom-Line Net Income | -40↓34.0% | -30↑45.2% | -55↑14.1% | -64↑5.5% | -68 | |
| EPS (Basic) | 1.24↑267.6% | -0.74↑61.7% | -1.93↑26.6% | -2.63↑43.2% | -4.63 | |
| EPS (Diluted) | 1.24↑267.6% | -0.74↑61.7% | -1.93↑26.6% | -2.63↑43.2% | -4.63 | |
| Weighted Average Shares | 50↑22.8% | 40↑42.5% | 28↑20.0% | 24↑42.5% | 17 | |
| Weighted Average Diluted Shares | 50↑22.8% | 40↑42.5% | 28↑20.0% | 24↑42.5% | 17 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.